ExLibris header image
SFX Logo
Title: Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Source:

Lipids in Health and Disease [1476-511X] Kumar, Shoba yr:2009


Collapse list of basic services Basic
Full text
Full text available via DOAJ Directory of Open Access Journals
GO
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Nicholls, Stephen J. "Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia." Therapeutics and Clinical Risk Management (2010): 183-190. Link to Full Text for this item Link to SFX for this item
2. Sang, Z. "Combined use of extended-release niacin and atorvastatin : safety and effects on lipid modification." Chinese medical journal 122.14 (2009): 1615-1620. Link to Full Text for this item Link to SFX for this item
3. Borden, William B. "Red yeast rice for dyslipidemia in statin-intolerant patients." Current Atherosclerosis Reports 12.1 (2010): 11-13. Link to SFX for this item
4. Cho, Kyu-hyang H. "Niacin improves renal lipid metabolism and slows progression in chronic kidney disease." Biochimica et biophysica acta 1800.1 (2010): 6-15. Link to SFX for this item
5. Bonnet, J. "Comparative effects of 10-mg versus 80-mg atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study." Clinical therapeutics 30.12 (2008): 2298-2313. Link to SFX for this item
6. Canner, ME L. "Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the coronary drug project)." The American journal of cardiology 95.2 (2005): 254-257. Link to SFX for this item
7. Karas, Richard H H. "Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia - The OCEANS study." American journal of cardiovascular drugs 8.2 (2008): 69-81. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced